Charles Mosseri - 20 Jun 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Issuer symbol
NVCT
Transactions as of
20 Jun 2025
Net transactions value
+$44,768
Form type
4
Filing time
24 Jun 2025, 17:14:35 UTC
Previous filing
20 Jun 2025
Next filing
29 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 24 Jun 2025 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $44,768 +5,603 +0.19% $7.99 2,981,806 20 Jun 2025 By Emerald Hill Ventures SARL SPF. F1
holding NVCT Common Stock 109,321 20 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.